Ipsen Bioinnovation Limited
Records under this name other than the patents Ipsen Bioinnovation Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Back to Ipsen Bioinnovation Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,066,451 | Methods for Purifying Clostridial Neurotoxin Formerly held In force · High confidence | In force | High confidence | |
| US 11,453,903 | Production of Activated Clostridial Neurotoxins Formerly held In force · High confidence | In force | High confidence | |
| US 9,115,350 | Carrier for targeting nerve cells Term ended Ended no later than Apr 26, 2026 · USPTO record | Term ended | Ended no later than Apr 26, 2026 | USPTO record |
| US 9,650,622 | Carrier for targeting nerve cells Term ended Ended no later than Apr 26, 2026 · USPTO record | Term ended | Ended no later than Apr 26, 2026 | USPTO record |
| US 10,266,816 | Carrier for targeting nerve cells Term ended Term ended Apr 26, 2026 · USPTO record | Term ended | Term ended Apr 26, 2026 | USPTO record |
| US 10,883,096 | Carrier for targeting nerve cells Term ended Term ended Apr 26, 2026 · USPTO record | Term ended | Term ended Apr 26, 2026 | USPTO record |
| US 11,248,219 | Fusion Proteins Comprising a Non-Cytotoxic Protease, a Translocation Domain, and a Targeting Moiety That Binds a Galanin Receptor and Methods for Treating, Preventing or Ameliorating Pain Using Such Fusion Proteins Lapsed on the fee record Ended Feb 15, 2026 · Medium confidence | Lapsed on the fee record | Ended Feb 15, 2026 | Medium confidence |
| US 9,234,011 | Transport protein which is used to introduce chemical compounds into nerve cells Formerly held Term ended Term ended Dec 30, 2025 · USPTO record | Term ended | Term ended Dec 30, 2025 | USPTO record |
| US 9,474,807 | Non-Cytotoxic Protein Conjugates Term ended Term ended Dec 1, 2025 · Medium confidence | Term ended | Term ended Dec 1, 2025 | Medium confidence |
| US 10,619,146 | Non-Cytotoxic Protein Conjugates Term ended Term ended Dec 1, 2025 · Medium confidence | Term ended | Term ended Dec 1, 2025 | Medium confidence |